St. Louis School of Medicine: Some Sarcoma Patients Improve With T Cell Immunotherapy
March 29, 2024
March 29, 2024
ST. LOUIS, Missouri, March 29 (TNSres) -- The Washington University St. Louis School of Medicine issued the following news release:
* * *
Strategy effective against some rare, aggressive sarcomas with no other treatment options
* * *
A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy -- in which the patients' own T cells are genetically modified to attack and kill c . . .
* * *
Strategy effective against some rare, aggressive sarcomas with no other treatment options
* * *
A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy -- in which the patients' own T cells are genetically modified to attack and kill c . . .